Furthermore, analysis of TCGA data indicated that high MTHFR expression was associated with improved overall survival (OS) and progression-free survival (PFS) in patients with LUAD, whereas only a nonsignificant trend was observed in patients with LUSC (Fig. 1G, H ).
← all excerpts
MTHFR functions as a metabolic checkpoint in NSCLC through SLC25A26-mediated SHMT2 inhibition.
1
—
—